PJP – Invesco Dynamic Pharmaceuticals ETF
Invesco Dynamic Pharmaceuticals ETF (PJP) is a Health ETF, issued by Invesco, $537M in assets, 0.57% expense ratio.
Returns as of Oct 23, 2026: 1 week +0.5%, 1 year +42.0%.
Tracks index of U.S. pharmaceutical companies. Invests in stocks of firms researching, developing, manufacturing, and distributing pharmaceuticals.
Top holdings
- AMGN – Amgen Inc, 5.7%
- ABT – Abbott Laboratories, 5.7%
- MRK – Merck & Company Inc, 5.5%
- ABBV – AbbVie Inc, 5.3%
- JNJ – Johnson & Johnson, 5.1%
- PFE – Pfizer Inc, 4.9%
- GILD – Gilead Sciences Inc, 4.9%
- LLY – Eli Lilly and Company, 4.8%
- CORT – Corcept Therapeutics Incorporated, 4.7%
- TVTX – Travere Therapeutics Inc, 3.7%
- AMRX – Amneal Pharmaceuticals, Inc. Class A Common Stock, 3.4%
- PRGO – Perrigo Company PLC, 3.4%
- HRMY – Harmony Biosciences Holdings, 3.3%
- OCUL – Ocular Therapeutix Inc, 3.2%
- REGN – Regeneron Pharmaceuticals Inc, 3.1%
- TARS – Tarsus Pharmaceuticals Inc, 3.0%
- LGND – Ligand Pharmaceuticals Incorporated, 3.0%
- BMY – Bristol-Myers Squibb Company, 2.9%
- LQDA – Liquidia Technologies Inc, 2.8%
- BIIB – Biogen Inc, 2.8%
- PBH – Prestige Brand Holdings Inc, 2.7%
- JAZZ – Jazz Pharmaceuticals PLC, 2.6%
- VTRS – Viatris Inc, 2.5%
- SUPN – Supernus Pharmaceuticals Inc, 2.3%
- INVA – Innoviva Inc, 2.3%